...
首页> 外文期刊>The American Journal of Surgery >Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review
【24h】

Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review

机译:可切除的肝门周围胆管癌的淋巴结清扫:系统评价

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Perihilar cholangiocarcinoma is usually unresectable at the time of diagnosis. Only few patients are candidates for a potential curative treatment. For those patients, prognosis is strongly related to negative resection margin and lymph node status. Thus, a certain benchmark of lymph node count is necessary to secure relevant lymph node recovery and to avoid understaging. However, the required minimum number of retrieved lymph nodes remains unclear for perihilar cholangiocarcinoma. The 7th American Joint Committee on Cancer tumor, nodes, metastases edition increased the requirement for the histologic examination of lymph nodes in perihilar cholangiocarcinoma patients from 3 to 15. The applicability of such recommendation appears difficult and questionable. Therefore, the purpose of this systematic review is to evaluate the number of retrieved lymph nodes for staging of patients undergoing surgery for perihilar cholangiocarcinoma.
机译:背景:肝门周围胆管癌通常在诊断时无法切除。只有极少数的患者可以进行潜在的治疗。对于这些患者,预后与阴性切缘和淋巴结状态密切相关。因此,一定的淋巴结计数基准是确保相关淋巴结恢复和避免分期不足的必要条件。但是,对于肝门周围胆管癌,所需的最少淋巴结数目仍不清楚。美国第七届癌症肿瘤,淋巴结转移联合委员会版本将对肝门周围胆管癌患者的淋巴结进行组织学检查的要求从3例增加到15例。这种建议的适用性似乎很困难且值得商question。因此,本系统综述的目的是评估取回的淋巴结的数量,以进行肝门周围胆管癌手术的患者分期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号